454 related articles for article (PubMed ID: 20561184)
1. Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism.
Kovacs MJ; Kahn SR; Wells PS; Anderson DA; Chagnon I; LE Gal G; Solymoss S; Crowther M; Perrier A; Ramsay T; Betancourt MT; White RH; Vickars L; Rodger MA
J Thromb Haemost; 2010 Sep; 8(9):1926-32. PubMed ID: 20561184
[TBL] [Abstract][Full Text] [Related]
2. The risk of recurrent venous thromboembolism in patients with unprovoked symptomatic deep vein thrombosis and asymptomatic pulmonary embolism.
Jiménez D; Díaz G; Marín E; Vidal R; Sueiro A; Yusen RD
Thromb Haemost; 2006 Mar; 95(3):562-6. PubMed ID: 16525588
[TBL] [Abstract][Full Text] [Related]
3. The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study.
Kyrle PA; Kammer M; Eischer L; Weltermann A; Minar E; Hirschl M; Heinze G; Eichinger S
J Thromb Haemost; 2016 Dec; 14(12):2402-2409. PubMed ID: 27696701
[TBL] [Abstract][Full Text] [Related]
4. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.
Prandoni P; Noventa F; Ghirarduzzi A; Pengo V; Bernardi E; Pesavento R; Iotti M; Tormene D; Simioni P; Pagnan A
Haematologica; 2007 Feb; 92(2):199-205. PubMed ID: 17296569
[TBL] [Abstract][Full Text] [Related]
5. Survival and recurrent venous thromboembolism in patients with first proximal or isolated distal deep vein thrombosis and no pulmonary embolism.
Barco S; Corti M; Trinchero A; Picchi C; Ambaglio C; Konstantinides SV; Dentali F; Barone M
J Thromb Haemost; 2017 Jul; 15(7):1436-1442. PubMed ID: 28439954
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysis.
Donadini MP; Ageno W; Antonucci E; Cosmi B; Kovacs MJ; Le Gal G; Ockelford P; Poli D; Prandoni P; Rodger M; Saccullo G; Siragusa S; Young L; Bonzini M; Caprioli M; Dentali F; Iorio A; Douketis JD
Thromb Haemost; 2014 Jan; 111(1):172-9. PubMed ID: 24154729
[TBL] [Abstract][Full Text] [Related]
7. Extended anticoagulation for unprovoked venous thromboembolism: a majority of patients should be treated.
Kearon C
J Thromb Thrombolysis; 2011 Apr; 31(3):295-300. PubMed ID: 21331558
[TBL] [Abstract][Full Text] [Related]
8. Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
Marik PE; Cavallazzi R
PLoS One; 2015; 10(11):e0143252. PubMed ID: 26587983
[TBL] [Abstract][Full Text] [Related]
9. The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism.
Douketis JD; Gu CS; Schulman S; Ghirarduzzi A; Pengo V; Prandoni P
Ann Intern Med; 2007 Dec; 147(11):766-74. PubMed ID: 18056660
[TBL] [Abstract][Full Text] [Related]
10. Superficial vein thrombosis and recurrent venous thromboembolism: a pooled analysis of two observational studies.
Galanaud JP; Bosson JL; Genty C; Presles E; Cucherat M; Sevestre MA; Quere I; Decousus H; Leizorovicz A
J Thromb Haemost; 2012 Jun; 10(6):1004-11. PubMed ID: 22429908
[TBL] [Abstract][Full Text] [Related]
11. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.
Khan F; Rahman A; Carrier M; Kearon C; Weitz JI; Schulman S; Couturaud F; Eichinger S; Kyrle PA; Becattini C; Agnelli G; Brighton TA; Lensing AWA; Prins MH; Sabri E; Hutton B; Pinede L; Cushman M; Palareti G; Wells GA; Prandoni P; Büller HR; Rodger MA;
BMJ; 2019 Jul; 366():l4363. PubMed ID: 31340984
[TBL] [Abstract][Full Text] [Related]
12. The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: new scenarios and opportunities.
Prandoni P; Barbar S; Milan M; Vedovetto V; Pesavento R
Eur J Intern Med; 2014 Jan; 25(1):25-30. PubMed ID: 24120221
[TBL] [Abstract][Full Text] [Related]
13. Long-term risk of venous thromboembolism recurrence after isolated superficial vein thrombosis.
Galanaud JP; Sevestre MA; Pernod G; Kahn SR; Genty C; Terrisse H; Brisot D; Gillet JL; Quéré I; Bosson JL
J Thromb Haemost; 2017 Jun; 15(6):1123-1131. PubMed ID: 28317330
[TBL] [Abstract][Full Text] [Related]
14. Incidence and predictors of venous thromboembolism recurrence after a first isolated distal deep vein thrombosis.
Galanaud JP; Sevestre MA; Genty C; Kahn SR; Pernod G; Rolland C; Diard A; Dupas S; Jurus C; Diamand JM; Quere I; Bosson JL;
J Thromb Haemost; 2014 Apr; 12(4):436-43. PubMed ID: 24450376
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Pinede L, Ninet J, Duhaut P et al for the Investigators of the 'Durée Optimale du Traitement Antivitamines K' (DOTAVK) study. Circulation 2001; 103: 2453-60.
Anand SS
Vasc Med; 2001 Nov; 6(4):269-70. PubMed ID: 11958396
[TBL] [Abstract][Full Text] [Related]
16. Thirteen-year trend in the persistence with vitamin K antagonists for venous thromboembolism in the UK: a cohort study.
Martinez C; Katholing A; Folkerts K; Rietbrock S
Curr Med Res Opin; 2018 Nov; 34(11):1985-1990. PubMed ID: 29798688
[TBL] [Abstract][Full Text] [Related]
17. Long-term recurrence of venous thromboembolism after short-term treatment of symptomatic isolated distal deep vein thrombosis: A cohort study.
Donadini MP; Dentali F; Pegoraro S; Pomero F; Brignone C; Guasti L; Steidl L; Ageno W
Vasc Med; 2017 Dec; 22(6):518-524. PubMed ID: 28732457
[TBL] [Abstract][Full Text] [Related]
18. Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
Rokx C; Borjas Howard JF; Smit C; Wit FW; Pieterman ED; Reiss P; Cannegieter SC; Lijfering WM; Meijer K; Bierman W; Tichelaar V; Rijnders BJA;
PLoS Med; 2020 May; 17(5):e1003101. PubMed ID: 32407386
[TBL] [Abstract][Full Text] [Related]
19. Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism.
Kearon C; Akl EA
Blood; 2014 Mar; 123(12):1794-801. PubMed ID: 24497538
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of patients with pulmonary embolism versus deep vein thrombosis: From the COMMAND VTE Registry.
Yamashita Y; Murata K; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Tsuyuki Y; Saga S; Nishimoto Y; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Yoshikawa Y; Shiomi H; Kato T; Makiyama T; Ono K; Nawada R; Onodera T; Kimura T;
Thromb Res; 2019 Dec; 184():50-57. PubMed ID: 31706068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
